Adoptive transfer of PEP-deficient CD8+ T cells from mice engineered to express a CD8+ TCR specific for ovalbumin (OT-I mice) resulted in enhanced clearance of ovalbumin-expressing EL4 thymoma tumors, and decreased sensitivity to TGFβ [170]. The gene discussed is CD8A; the disease is thymoma.